Modeling the transmission and prevention of infectious disease
This volume focuses on blocking disease transmission and the ecological perspective of pathogens and pathogenic processes. The chapters on blocking transmission cover the environmental safety of space flight, biocides and biocide resistance, as well as infection control in healthcare facilities. The...
Saved in:
| Other Authors | |
|---|---|
| Format | Electronic eBook |
| Language | English |
| Published |
Cham, Switzerland :
Springer,
[2017]
|
| Series | Advances in environmental microbiology ;
v. 4. |
| Subjects | |
| Online Access | Full text |
| ISBN | 9783319606163 9783319606149 |
| ISSN | 2366-3324 ; |
| Physical Description | 1 online resource |
Cover
Table of Contents:
- Dedication; Series Preface; Volume Preface; Contents; Part I: Preventing the Environmental Transmission of Infections; Chapter 1: Preventing Infectious Diseases in Spacecraft and Space Habitats; 1.1 Introduction; 1.2 Microbiological Risks and Their Adverse Effects; 1.3 Strategy to Mitigate Microbiological Risks; 1.4 Crew Health; 1.5 Acceptability Limits and Sampling Schedules; 1.6 Environmental Microbial Monitoring; 1.7 Water Microbial Monitoring; 1.8 Food Microbial Monitoring; 1.9 Payload Reviews; 1.10 Conclusions; References; Chapter 2: Bacterial Resistance to Hospital Disinfection.
- 2.1 Introduction2.2 Types of Biocides and Mode of Action; 2.2.1 Cationic Antimicrobial Agents; 2.2.2 Quaternary Ammonium Compounds; 2.2.3 Biguanides; 2.2.4 Peroxygens; 2.2.4.1 Hydrogen Peroxide; 2.2.4.2 Peracetic Acid; 2.2.5 Alcohols; 2.2.6 Aldehydes; 2.2.7 Phenolics; 2.2.8 Halogen-Releasing Agents; 2.2.8.1 Chlorine-Releasing Agents; 2.2.8.2 Iodophors; 2.2.9 Others; 2.3 Resistance to Biocides; 2.3.1 Intrinsic Resistance to Biocides; 2.3.1.1 Spore-Forming Bacteria; 2.3.1.2 Mycobacteria; 2.3.1.3 Other Gram-Positive Bacteria; 2.3.1.4 Gram-Negative Bacteria; 2.3.2 Acquired Resistance to Biocides.
- 2.3.2.1 Impermeability2.3.2.2 Target Alteration; 2.3.2.3 Efflux Systems; 2.4 Biofilms; 2.5 Link to Antibiotic Resistance; 2.6 Problems and Challenges Associated with Testing Biocide Efficacy; References; Chapter 3: Disinfection of Microbial Aerosols; 3.1 Introduction; 3.2 Microbial Aerosol Disinfection Methods; 3.3 Applications of Microbial Aerosol Disinfection; 3.4 Ultraviolet Inactivation; 3.4.1 Techniques Used; 3.4.2 Laboratory Studies; 3.4.3 Field Studies; 3.4.4 Effects of Relative Humidity on UVGI; 3.4.5 Adverse Effects; 3.5 HEPA Filtration; 3.5.1 Types of Installation.
- 3.5.2 Use of HEPA Filtration for Exhaust Air3.5.3 Use of HEPA Filtration for Recirculation Within a Room; 3.5.4 Maintenance of HEPA Filters; 3.6 Photocatalytic Oxidation; 3.7 Nonthermal Plasma; 3.8 Plasmacluster Ion Technology; 3.9 Microwave Irradiation; 3.10 Ion Emission; 3.11 Short-Term Thermal Treatment; 3.12 Application of Nanotechnology; 3.13 Application of Natural Products; 3.14 Conclusions; References; Part II: Understanding the Ecology of Infectious Disease; Chapter 4: The Role of the Indigenous Gut Microbiota in Human Health and Disease.
- 4.1 Introduction: The Human Indigenous Gut Microbiota4.2 Association Between the Gut Microbiota and Chronic Gastrointestinal Disorders; 4.2.1 Irritable Bowel Syndrome and Irritable Bowel Disorder; 4.2.2 Colorectal Cancer; 4.3 Influence of the Indigenous Gut Microbiota on Obesity; 4.4 Allergies and Asthma; 4.4.1 Hygiene Hypothesis: Origin and Development; 4.4.2 Gut Microbiota and the Hygiene Hypothesis; 4.4.3 Food Allergies; 4.4.4 Impact of Probiotics and Microbial Metabolites on Allergic Disease; 4.4.5 Impact of Birth Method and Breastfeeding on Manifestation of Allergies and Asthma.